Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis
<p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of...
Ausführliche Beschreibung
Autor*in: |
Liang Xiaohui [verfasserIn] Wang Danying [verfasserIn] Wang Yan [verfasserIn] Zhou Zhiqiang [verfasserIn] Zhang Juan [verfasserIn] Li Jinsong [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2012 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Diagnostic Pathology - BMC, 2005, 7(2012), 1, p 84 |
---|---|
Übergeordnetes Werk: |
volume:7 ; year:2012 ; number:1, p 84 |
Links: |
---|
DOI / URN: |
10.1186/1746-1596-7-84 |
---|
Katalog-ID: |
DOAJ037243632 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ037243632 | ||
003 | DE-627 | ||
005 | 20230308001805.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2012 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/1746-1596-7-84 |2 doi | |
035 | |a (DE-627)DOAJ037243632 | ||
035 | |a (DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RB1-214 | |
100 | 0 | |a Liang Xiaohui |e verfasserin |4 aut | |
245 | 1 | 0 | |a Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis |
264 | 1 | |c 2012 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a <p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< | ||
650 | 4 | |a Aurora kinase A | |
650 | 4 | |a Aurora kinase B | |
650 | 4 | |a Chondrosarcoma | |
653 | 0 | |a Pathology | |
700 | 0 | |a Wang Danying |e verfasserin |4 aut | |
700 | 0 | |a Wang Yan |e verfasserin |4 aut | |
700 | 0 | |a Zhou Zhiqiang |e verfasserin |4 aut | |
700 | 0 | |a Zhang Juan |e verfasserin |4 aut | |
700 | 0 | |a Li Jinsong |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Diagnostic Pathology |d BMC, 2005 |g 7(2012), 1, p 84 |w (DE-627)503328960 |w (DE-600)2210518-9 |x 17461596 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2012 |g number:1, p 84 |
856 | 4 | 0 | |u https://doi.org/10.1186/1746-1596-7-84 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f |z kostenfrei |
856 | 4 | 0 | |u http://www.diagnosticpathology.org/content/7/1/84 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1746-1596 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 7 |j 2012 |e 1, p 84 |
author_variant |
l x lx w d wd w y wy z z zz z j zj l j lj |
---|---|
matchkey_str |
article:17461596:2012----::xrsinfuoaiaeadicodoacmadtrlt |
hierarchy_sort_str |
2012 |
callnumber-subject-code |
RB |
publishDate |
2012 |
allfields |
10.1186/1746-1596-7-84 doi (DE-627)DOAJ037243632 (DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f DE-627 ger DE-627 rakwb eng RB1-214 Liang Xiaohui verfasserin aut Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< Aurora kinase A Aurora kinase B Chondrosarcoma Pathology Wang Danying verfasserin aut Wang Yan verfasserin aut Zhou Zhiqiang verfasserin aut Zhang Juan verfasserin aut Li Jinsong verfasserin aut In Diagnostic Pathology BMC, 2005 7(2012), 1, p 84 (DE-627)503328960 (DE-600)2210518-9 17461596 nnns volume:7 year:2012 number:1, p 84 https://doi.org/10.1186/1746-1596-7-84 kostenfrei https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f kostenfrei http://www.diagnosticpathology.org/content/7/1/84 kostenfrei https://doaj.org/toc/1746-1596 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_168 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2012 1, p 84 |
spelling |
10.1186/1746-1596-7-84 doi (DE-627)DOAJ037243632 (DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f DE-627 ger DE-627 rakwb eng RB1-214 Liang Xiaohui verfasserin aut Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< Aurora kinase A Aurora kinase B Chondrosarcoma Pathology Wang Danying verfasserin aut Wang Yan verfasserin aut Zhou Zhiqiang verfasserin aut Zhang Juan verfasserin aut Li Jinsong verfasserin aut In Diagnostic Pathology BMC, 2005 7(2012), 1, p 84 (DE-627)503328960 (DE-600)2210518-9 17461596 nnns volume:7 year:2012 number:1, p 84 https://doi.org/10.1186/1746-1596-7-84 kostenfrei https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f kostenfrei http://www.diagnosticpathology.org/content/7/1/84 kostenfrei https://doaj.org/toc/1746-1596 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_168 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2012 1, p 84 |
allfields_unstemmed |
10.1186/1746-1596-7-84 doi (DE-627)DOAJ037243632 (DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f DE-627 ger DE-627 rakwb eng RB1-214 Liang Xiaohui verfasserin aut Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< Aurora kinase A Aurora kinase B Chondrosarcoma Pathology Wang Danying verfasserin aut Wang Yan verfasserin aut Zhou Zhiqiang verfasserin aut Zhang Juan verfasserin aut Li Jinsong verfasserin aut In Diagnostic Pathology BMC, 2005 7(2012), 1, p 84 (DE-627)503328960 (DE-600)2210518-9 17461596 nnns volume:7 year:2012 number:1, p 84 https://doi.org/10.1186/1746-1596-7-84 kostenfrei https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f kostenfrei http://www.diagnosticpathology.org/content/7/1/84 kostenfrei https://doaj.org/toc/1746-1596 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_168 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2012 1, p 84 |
allfieldsGer |
10.1186/1746-1596-7-84 doi (DE-627)DOAJ037243632 (DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f DE-627 ger DE-627 rakwb eng RB1-214 Liang Xiaohui verfasserin aut Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< Aurora kinase A Aurora kinase B Chondrosarcoma Pathology Wang Danying verfasserin aut Wang Yan verfasserin aut Zhou Zhiqiang verfasserin aut Zhang Juan verfasserin aut Li Jinsong verfasserin aut In Diagnostic Pathology BMC, 2005 7(2012), 1, p 84 (DE-627)503328960 (DE-600)2210518-9 17461596 nnns volume:7 year:2012 number:1, p 84 https://doi.org/10.1186/1746-1596-7-84 kostenfrei https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f kostenfrei http://www.diagnosticpathology.org/content/7/1/84 kostenfrei https://doaj.org/toc/1746-1596 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_168 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2012 1, p 84 |
allfieldsSound |
10.1186/1746-1596-7-84 doi (DE-627)DOAJ037243632 (DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f DE-627 ger DE-627 rakwb eng RB1-214 Liang Xiaohui verfasserin aut Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< Aurora kinase A Aurora kinase B Chondrosarcoma Pathology Wang Danying verfasserin aut Wang Yan verfasserin aut Zhou Zhiqiang verfasserin aut Zhang Juan verfasserin aut Li Jinsong verfasserin aut In Diagnostic Pathology BMC, 2005 7(2012), 1, p 84 (DE-627)503328960 (DE-600)2210518-9 17461596 nnns volume:7 year:2012 number:1, p 84 https://doi.org/10.1186/1746-1596-7-84 kostenfrei https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f kostenfrei http://www.diagnosticpathology.org/content/7/1/84 kostenfrei https://doaj.org/toc/1746-1596 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_168 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2012 1, p 84 |
language |
English |
source |
In Diagnostic Pathology 7(2012), 1, p 84 volume:7 year:2012 number:1, p 84 |
sourceStr |
In Diagnostic Pathology 7(2012), 1, p 84 volume:7 year:2012 number:1, p 84 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Aurora kinase A Aurora kinase B Chondrosarcoma Pathology |
isfreeaccess_bool |
true |
container_title |
Diagnostic Pathology |
authorswithroles_txt_mv |
Liang Xiaohui @@aut@@ Wang Danying @@aut@@ Wang Yan @@aut@@ Zhou Zhiqiang @@aut@@ Zhang Juan @@aut@@ Li Jinsong @@aut@@ |
publishDateDaySort_date |
2012-01-01T00:00:00Z |
hierarchy_top_id |
503328960 |
id |
DOAJ037243632 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ037243632</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308001805.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2012 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1746-1596-7-84</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ037243632</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RB1-214</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Liang Xiaohui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aurora kinase A</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aurora kinase B</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chondrosarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pathology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wang Danying</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wang Yan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhou Zhiqiang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang Juan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Jinsong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Diagnostic Pathology</subfield><subfield code="d">BMC, 2005</subfield><subfield code="g">7(2012), 1, p 84</subfield><subfield code="w">(DE-627)503328960</subfield><subfield code="w">(DE-600)2210518-9</subfield><subfield code="x">17461596</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:1, p 84</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/1746-1596-7-84</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.diagnosticpathology.org/content/7/1/84</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1746-1596</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_168</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2012</subfield><subfield code="e">1, p 84</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Liang Xiaohui |
spellingShingle |
Liang Xiaohui misc RB1-214 misc Aurora kinase A misc Aurora kinase B misc Chondrosarcoma misc Pathology Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis |
authorStr |
Liang Xiaohui |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)503328960 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RB1-214 |
illustrated |
Not Illustrated |
issn |
17461596 |
topic_title |
RB1-214 Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis Aurora kinase A Aurora kinase B Chondrosarcoma |
topic |
misc RB1-214 misc Aurora kinase A misc Aurora kinase B misc Chondrosarcoma misc Pathology |
topic_unstemmed |
misc RB1-214 misc Aurora kinase A misc Aurora kinase B misc Chondrosarcoma misc Pathology |
topic_browse |
misc RB1-214 misc Aurora kinase A misc Aurora kinase B misc Chondrosarcoma misc Pathology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Diagnostic Pathology |
hierarchy_parent_id |
503328960 |
hierarchy_top_title |
Diagnostic Pathology |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)503328960 (DE-600)2210518-9 |
title |
Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis |
ctrlnum |
(DE-627)DOAJ037243632 (DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f |
title_full |
Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis |
author_sort |
Liang Xiaohui |
journal |
Diagnostic Pathology |
journalStr |
Diagnostic Pathology |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2012 |
contenttype_str_mv |
txt |
author_browse |
Liang Xiaohui Wang Danying Wang Yan Zhou Zhiqiang Zhang Juan Li Jinsong |
container_volume |
7 |
class |
RB1-214 |
format_se |
Elektronische Aufsätze |
author-letter |
Liang Xiaohui |
doi_str_mv |
10.1186/1746-1596-7-84 |
author2-role |
verfasserin |
title_sort |
expression of aurora kinase a and b in chondrosarcoma and its relationship with the prognosis |
callnumber |
RB1-214 |
title_auth |
Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis |
abstract |
<p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< |
abstractGer |
<p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< |
abstract_unstemmed |
<p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p< |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_168 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
1, p 84 |
title_short |
Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis |
url |
https://doi.org/10.1186/1746-1596-7-84 https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f http://www.diagnosticpathology.org/content/7/1/84 https://doaj.org/toc/1746-1596 |
remote_bool |
true |
author2 |
Wang Danying Wang Yan Zhou Zhiqiang Zhang Juan Li Jinsong |
author2Str |
Wang Danying Wang Yan Zhou Zhiqiang Zhang Juan Li Jinsong |
ppnlink |
503328960 |
callnumber-subject |
RB - Pathology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1186/1746-1596-7-84 |
callnumber-a |
RB1-214 |
up_date |
2024-07-04T00:28:36.467Z |
_version_ |
1803606206939398144 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ037243632</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308001805.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2012 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1746-1596-7-84</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ037243632</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJffc0f91a78d44a0993e43a659b0b783f</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RB1-214</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Liang Xiaohui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<Abstract</p< <p<Purpose</p< <p<To investigate the expression of Aurora Kinase A and B in patients with chondrosarcoma and consider it as a prognostic marker and molecular target of therapy.</p< <p<Methods</p< <p<To evaluate the relationship of the Aurora Kinase A and B and the clinical pathological parameters and prognosis of chondrosarcoma. 72 case chondrosarcoma and 42 case chondroma were performed immunohistochemistry on the tissue microarray paraffin sections. The survival time of patients was followed-up.</p< <p<Results</p< <p<The expression of Aurora Kinase A and B in chondrosarcoma was significantly higher than that in chondroma (<it<p<0.01</it<). There were differences about the expression of Aurora Kinase A and B in chondrosarcoma between the recurrence group and the non-recurrence group, metastatic group and non-metastatic group (<it<p<0.05</it<), but not age and gender (<it<p<0.05</it<). The expression of Aurora Kinase A and B were significantly lower in group low grade conventional chondrosarcoma than that in groups medium and high grade conventional chondrosarcoma (<it<p<0.01</it<). The expression of Aurora Kinase A and B in chondrosarcoma showed a positive correlation (<it<p<0.01</it<). According to the Kaplan Meier analysis and multivariate Cox regression analysis, the survival rate was significantly different between the patients with positive Aurora Kinase A and the patients with negative expression (<it<p<0.05</it<) and Aurora Kinase A expression was an independent risk marker of survival(<it<HR=11.263</it<, <it<95%CI: 2.317–54.748, P=0.003</it<).</p< <p<Conclusion</p< <p<Both the Aurora Kinase A and B might involve in the oncogenic, invasive and metastatic process of chondrosarcoma; however, the mechanism is still unclear. The Aurora Kinase A and B could be used as a new prognostic marker and molecular therapeutic target for chondrosarcoma.</p< <p<Virtual Slide</p< <p<The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9101494267377096.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aurora kinase A</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aurora kinase B</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chondrosarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pathology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wang Danying</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wang Yan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhou Zhiqiang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang Juan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Jinsong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Diagnostic Pathology</subfield><subfield code="d">BMC, 2005</subfield><subfield code="g">7(2012), 1, p 84</subfield><subfield code="w">(DE-627)503328960</subfield><subfield code="w">(DE-600)2210518-9</subfield><subfield code="x">17461596</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:1, p 84</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/1746-1596-7-84</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ffc0f91a78d44a0993e43a659b0b783f</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.diagnosticpathology.org/content/7/1/84</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1746-1596</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_168</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2012</subfield><subfield code="e">1, p 84</subfield></datafield></record></collection>
|
score |
7.3989544 |